BlackRock Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$30M Sell
850,153
-26,676
-3% -$901K 0.03% 414
2016
Q3
$30.5M Buy
876,829
+58,484
+7% +$2.05M 0.03% 398
2016
Q2
$30.6M Buy
818,345
+85,952
+12% +$3.23M 0.03% 410
2016
Q1
$29.6M Sell
732,393
-323,247
-31% -$12M 0.03% 434
2015
Q4
$38M Sell
1,055,640
-117,121
-10% -$4.24M 0.04% 372
2015
Q3
$37.5M Buy
1,172,761
+26,843
+2% +$914K 0.04% 364
2015
Q2
$39M Sell
1,145,918
-625,502
-35% -$21.1M 0.04% 356
2015
Q1
$59.9M Buy
1,771,420
+317,326
+22% +$11.1M 0.06% 292
2014
Q4
$51.1M Sell
1,454,094
-33,389
-2% -$1.12M 0.05% 331
2014
Q3
$48.7M Sell
1,487,483
-7,021
-0.5% -$239K 0.05% 355
2014
Q2
$50.8M Buy
1,494,504
+708,874
+90% +$24.3M 0.05% 349
2014
Q1
$27.5M Buy
785,630
+23,993
+3% +$846K 0.03% 484
2013
Q4
$27.8M Sell
761,637
-276,730
-27% -$10.2M 0.03% 473
2013
Q3
$35.9M Sell
1,038,367
-283,205
-21% -$9.91M 0.04% 402
2013
Q2
$44.7M Buy
+1,321,572
New +$43.9M 0.05% 338

Other funds holding ACH

BlackRock Advisors's ACH Position: Q4 2016 in Review

BlackRock Advisors reduced its Accendra Health (ACH) stake by 3% in Q4 2016, selling an estimated $901K and leaving 850,153 shares worth $30M. The position accounts for 0.03% of the portfolio, ranked #414.

BlackRock Advisors first reported a position in ACH in Q2 2013 and has held it in 15 quarters since. The position peaked at $59.9M in Q1 2015. 285 funds tracked by Wall St. Rank hold ACH as of Q4 2016.

  • BlackRock Advisors held 850,153 shares of Accendra Health worth $30M as of Q4 2016.
  • BlackRock Advisors sold 26,676 Accendra Health shares in Q4 2016, an estimated $901K.
  • Accendra Health made up 0.03% of BlackRock Advisors's portfolio in Q4 2016, its #414 holding.
  • BlackRock Advisors first reported a position in Accendra Health in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Accendra Health position peaked at $59.9M in Q1 2015.
  • 285 funds tracked by Wall St. Rank held Accendra Health as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.